| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adverse drug reactions in therapeutic hypothermia after cardiac arrest
|
Witcher, Robert
|
|
2017
|
|
3 |
p. 101-111
|
artikel
|
| 2 |
An update on the safety of current therapies for Alzheimer’s disease: focus on rivastigmine
|
Khoury, Rita
|
|
2018
|
|
3 |
p. 171-178
|
artikel
|
| 3 |
A randomized, crossover, placebo-controlled clinical trial to assess the sensitivity of the CRCDS Mini-Sim to the next-day residual effects of zopiclone
|
Simen, Arthur A.
|
|
2015
|
|
3 |
p. 86-97
|
artikel
|
| 4 |
Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes
|
Martinez-Raga, Jose
|
|
2017
|
|
3 |
p. 87-99
|
artikel
|
| 5 |
Can supporting health literacy reduce medication-related harm in older adults?
|
Parekh, Nikesh
|
|
2018
|
|
3 |
p. 167-170
|
artikel
|
| 6 |
Evidence-based case report: multiple thrombotic episodes associated with lenalidomide and dexamethasone therapy for multiple myeloma
|
Rushworth, Gordon F.
|
|
2012
|
|
3 |
p. 115-122
|
artikel
|
| 7 |
Factors associated with antidepressant use in residents with and without dementia in Australian aged care facilities
|
Hiltunen, Henna
|
|
2016
|
|
3 |
p. 79-88
|
artikel
|
| 8 |
Fingolimod and cardiac risk: latest findings and clinical implications
|
Vargas, Wendy S
|
|
2013
|
|
3 |
p. 119-124
|
artikel
|
| 9 |
Immunogenicity and other problems associated with the use of biopharmaceuticals
|
Tovey, Michael G.
|
|
2011
|
|
3 |
p. 113-128
|
artikel
|
| 10 |
Increased levels of urinary phenylacetylglycine associated with mitochondrial toxicity in a model of drug-induced phospholipidosis
|
Doessegger, Lucette
|
|
2013
|
|
3 |
p. 101-114
|
artikel
|
| 11 |
Is tenofovir/emtricitabine teratogenic?
|
Jibril, Murtala
|
|
2013
|
|
3 |
p. 115-117
|
artikel
|
| 12 |
Likelihood of reporting medication errors in hospitalized children: a survey of nurses and physicians
|
Rishoej, Rikke Mie
|
|
2018
|
|
3 |
p. 179-192
|
artikel
|
| 13 |
Medication misuse among elderly population in Pakistan
|
Saleem, Ahsan
|
|
2016
|
|
3 |
p. 122-123
|
artikel
|
| 14 |
Medication safety in neonatal care: a review of medication errors among neonates
|
Krzyzaniak, Natalia
|
|
2016
|
|
3 |
p. 102-119
|
artikel
|
| 15 |
Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycle
|
Tay, Hui Sian
|
|
2014
|
|
3 |
p. 121-128
|
artikel
|
| 16 |
No association of maternal vitamin E intake with higher risk of cardiovascular malformations in children: a population-based case–control study
|
Szilasi, Mária
|
|
2011
|
|
3 |
p. 77-86
|
artikel
|
| 17 |
Opioid formulations with sequestered naltrexone: a perspective review
|
Taylor, Robert
|
|
2014
|
|
3 |
p. 129-137
|
artikel
|
| 18 |
Outcomes in patients with gram-negative sepsis treated with gentamicin
|
Pillans, Peter
|
|
2012
|
|
3 |
p. 109-113
|
artikel
|
| 19 |
Pharmacy interventions on prescribing in nursing homes: from evidence to practice
|
Hughes, Carmel M.
|
|
2011
|
|
3 |
p. 103-112
|
artikel
|
| 20 |
Profound hyperkalemia associated with thromboprophylactic enoxaparin
|
Scalese, Michael Joseph
|
|
2016
|
|
3 |
p. 120-121
|
artikel
|
| 21 |
Propofol-associated QTc prolongation
|
Scalese, Michael J.
|
|
2016
|
|
3 |
p. 68-78
|
artikel
|
| 22 |
Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications
|
Heidelbaugh, Joel J.
|
|
2013
|
|
3 |
p. 125-133
|
artikel
|
| 23 |
Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety
|
Phillips, Cameron J.
|
|
2014
|
|
3 |
p. 118-120
|
artikel
|
| 24 |
Revisiting the reported signal of acute pancreatitis with rasburicase: an object lesson in pharmacovigilance
|
Hauben, Manfred
|
|
2016
|
|
3 |
p. 94-101
|
artikel
|
| 25 |
Right ventricle failure associated wıth trastuzumab
|
Bayar, Nermin
|
|
2015
|
|
3 |
p. 98-102
|
artikel
|
| 26 |
Risk of intracranial hypertension with intrauterine levonorgestrel
|
Etminan, Mahyar
|
|
2015
|
|
3 |
p. 110-113
|
artikel
|
| 27 |
Risks and benefits of (pharmaco)epidemiology
|
Wise, Lesley
|
|
2011
|
|
3 |
p. 95-102
|
artikel
|
| 28 |
Risks associated with tiotropium in chronic obstructive pulmonary disease: overview of the evidence to date
|
Loke, Yoon K.
|
|
2012
|
|
3 |
p. 123-131
|
artikel
|
| 29 |
Safety of dipeptidyl peptidase 4 inhibitors: a perspective review
|
Karagiannis, Thomas
|
|
2014
|
|
3 |
p. 138-146
|
artikel
|
| 30 |
Safety of high-dose doripenem in adult patients with cystic fibrosis
|
Strawbridge, Seth
|
|
2016
|
|
3 |
p. 89-93
|
artikel
|
| 31 |
Safety of statins: an update
|
Hu, Miao
|
|
2012
|
|
3 |
p. 133-144
|
artikel
|
| 32 |
Safety risks with investigational drugs: Pharmacy practices and perceptions in the veterans affairs health system
|
Cruz, Jennifer L.
|
|
2015
|
|
3 |
p. 103-109
|
artikel
|
| 33 |
Systematic review of treatments for Stevens–Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality
|
Roujeau, Jean-Claude
|
|
2011
|
|
3 |
p. 87-94
|
artikel
|
| 34 |
The SENATOR project: developing and trialling a novel software engine to optimize medications and nonpharmacological therapy in older people with multimorbidity and polypharmacy
|
Soiza, Roy L.
|
|
2017
|
|
3 |
p. 81-85
|
artikel
|
Tijdschrift beschrijving